Latest filing published 26 Mar 2021 for Cipher Pharmaceuticals Inc., €21k.
No signal scores available.
Scott Langille appears in our data through filings on Cipher Pharmaceuticals Inc. shares, published by SEDI. The record holds 2 filings, for trades running from 3 July 2020 to 23 March 2021.
Every open-market trade on record is a purchase: 1 purchase worth €21k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2021: 1 purchase and no sales on the market.
The record was last updated on 26 March 2021 with an open-market purchase (€21k) in Cipher Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations